These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 450956)

  • 1. [On the polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behaviour of barbital (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979; 34(3):164-7. PubMed ID: 450956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the polymorphism of barbiturates in powders and tablets. Part 2: On the infrared spectroscopy and the X-ray diffractometry of barbital (author's transl)].
    Hollenbach K; Mezösi J; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979 Apr; 34(4):240-2. PubMed ID: 482331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the polymorphism of barbiturates in powders and tablets - Part 3: The effect of the pressing power on the modification of barbital (author's transl)].
    Pintye-Hódi K; Hollenbach K
    Pharmazie; 1979 Dec; 34(12):807-8. PubMed ID: 545349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the polymorphism of Barbiturates in powers and tablets. Part 5: The dissolution of recrystallized barbital substances and their release from tablet (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Feb; 35(2):95-8. PubMed ID: 7384189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the polymorphism of barbiturates in powders and tablets. 6: Properties and behaviour of a spray-dried barbital preparation].
    Matzkó-Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1982 Aug; 37(8):562-5. PubMed ID: 7146063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the polymorphism of barbital.
    Grabowska I; Kaliszan R
    Pol J Pharmacol Pharm; 1976; 28(5):529-36. PubMed ID: 1012979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the compression behaviour of spray-dried sulphathiazole (author's transl)].
    Kala H; Moldenhauer H; Giese R; Kedvessy G; Selmeczi B; Pintye-Hódi K
    Pharmazie; 1982 Feb; 37(2):129-31. PubMed ID: 7071118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of 1:1 complex of barbital with 1-methylimidazole.
    Wang A; Craven BM
    J Pharm Sci; 1979 Mar; 68(3):361-3. PubMed ID: 423128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct preparation of solid particulates of aminopyrine-barbital complex (pyrabital) from droplets by a spray-drying technique.
    Kawashima Y; Lin SY; Ueda M; Takenaka H; Ando Y
    J Pharm Sci; 1983 May; 72(5):514-8. PubMed ID: 6864497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmaceutical studies on physical properties of solid form drugs. IV. Behavior of powders in tabletting (author's transl)].
    Kigasawa K; Iimura H; Tanizaki A; Sugahara S; Watabe K; Sugimura H; Shimizu H
    Yakugaku Zasshi; 1979 Jul; 99(7):723-9. PubMed ID: 544790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Barbital buffer in tablets as a solvent for complement fixation test (CFT)].
    Królak M; Janicki S; Starostka K; Błaszczyk B
    Pol Arch Weter; 1982; 23(2):111-22. PubMed ID: 7167394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of biological activity of organic substances by measuring the physico-chemical parameters (author's transl)].
    Avico U; Cingolani E; Ciranni Signoretti E; Zuccaro P
    Ann Ist Super Sanita; 1978; 14(4):769-80. PubMed ID: 756691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unexpected interactions of some psychotropic drugs with barbital and pentobarbital effects in mice (author's transl)].
    Simon P; Chermat R; Doaré L; Bourin M; Farinotti R
    J Pharmacol; 1982; 13(2):241-52. PubMed ID: 7098486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The polymorphism of drugs in powders and tablets. 4. The effect of the polymorphism of drugs on the physical properties and drug release of phenobarbital tablets].
    Szabó-Réveśz P; Pintye-Hódi K; Miseta M; Selmeczi B; Kedvessy G; Traue J; Kala H; Wenzel U
    Pharmazie; 1987 Mar; 42(3):179-81. PubMed ID: 3602074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmaceutical studies on physical properties of powders. IV. Study on the estimation of flow rate through horizontal circular orifice (author's transl)].
    Kigazawa K; Iimura H; Watabe K
    Yakugaku Zasshi; 1974 Jan; 94(1):88-92. PubMed ID: 4859052
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of crystal forms of some barbiturates on their pharmaceutical properties. Part 1: Phenobarbitone.
    El-Banna HM; Ebian AR; Ismail AA
    Pharmazie; 1975 Jul; 30(7):455-60. PubMed ID: 1178762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PROPOSALS FOR THE DEUTSCHE ARZNEIBUCH. 17. BARBITAL AND SODIUM BARBITAL].
    POETHKE W; PREUSSLER M
    Pharmazie; 1964 Jun; 19():394-9. PubMed ID: 14254485
    [No Abstract]   [Full Text] [Related]  

  • 19. The assay of tablets containing barbiturates by automatic conductometric titration; a study of content uniformity.
    Schute JB; Maussen LH
    Pharm Weekbl; 1966 Sep; 101(37):809-22. PubMed ID: 5917274
    [No Abstract]   [Full Text] [Related]  

  • 20. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.
    Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.